Literature DB >> 21862080

Long-term urological impact of fetal myelomeningocele closure.

Douglass B Clayton1, Stacy T Tanaka, Lisa Trusler, John C Thomas, John C Pope, Mark C Adams, John W Brock.   

Abstract

PURPOSE: Between 1997 and 2002 a large number of fetal myelomeningocele closures were performed at our institution. Previously early reports showed little improvement in neonatal bladder function after fetal back closure. We evaluated the long-term urological impact of this procedure.
MATERIALS AND METHODS: Using a combination of retrospective review and survey questionnaire we reviewed the records of 28 patients in whom fetal myelomeningocele closure was done at our institution between 1997 and 2002. The areas addressed included medical management for neurogenic bladder and bowel, need for lower urinary tract reconstruction and functional bladder assessment by videourodynamics. Parameters after fetal myelomeningocele closure were compared to those of 33 age and sex matched patients with myelomeningocele who underwent standard postnatal closure.
RESULTS: We reviewed the records of 28 patients after fetal myelomeningocele closure. At a mean age of 9.6 years 23 used clean intermittent catheterization to manage the bladder, 24 required a bowel regimen to manage constipation and 6 underwent lower urinary tract reconstruction with enterocystoplasty and a catheterizable bladder channel. Videourodynamics performed in 14 patients at a mean age of 7.4 years revealed decreased bladder capacity in 71%, detrusor overactivity in 35% and increased detrusor pressure in 25%. Compared to age and sex matched children who underwent postnatal closure we noted no significant differences in bladder management, urinary tract surgery or urodynamics.
CONCLUSIONS: Neurogenic bowel and bladder management continues to be a significant issue for patients after fetal myelomeningocele closure. After fetal surgery patients should be followed closely, similar to patients who undergo postnatal closure.
Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21862080     DOI: 10.1016/j.juro.2011.04.005

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

Review 1.  In utero intervention for urologic diseases.

Authors:  Douglass B Clayton; John W Brock
Journal:  Nat Rev Urol       Date:  2012-02-21       Impact factor: 14.432

Review 2.  Urological Outcomes of Myelomeningocele and Lipomeningocele.

Authors:  Yvonne Y Chan; Samantha K Sandlin; Eric A Kurzrock
Journal:  Curr Urol Rep       Date:  2017-05       Impact factor: 3.092

Review 3.  Fetal surgery for myelomeningocele is effective: a critical look at the whys.

Authors:  Martin Meuli; Ueli Moehrlen
Journal:  Pediatr Surg Int       Date:  2014-06-08       Impact factor: 1.827

4.  Low level myelomeningoceles: do they need prenatal surgery?

Authors:  Pierre-Aurelien Beuriat; Isabelle Poirot; Frederic Hameury; Delphine Demede; Kieron J Sweeney; Alexandru Szathmari; Federico Di Rocco; Carmine Mottolese
Journal:  Childs Nerv Syst       Date:  2019-03-27       Impact factor: 1.475

5.  Bladder Function After Fetal Surgery for Myelomeningocele.

Authors:  John W Brock; Michael C Carr; N Scott Adzick; Pamela K Burrows; John C Thomas; Elizabeth A Thom; Lori J Howell; Jody A Farrell; Mary E Dabrowiak; Diana L Farmer; Earl Y Cheng; Bradley P Kropp; Anthony A Caldamone; Dorothy I Bulas; Susan Tolivaisa; Laurence S Baskin
Journal:  Pediatrics       Date:  2015-10       Impact factor: 7.124

Review 6.  Understanding Sociodemographic Disparities in Maternal-Fetal Surgery Study Participation.

Authors:  Abigail Wilpers; Anna Y Lynn; Barbara Eichhorn; Amy B Powne; Megan Lagueux; Janene Batten; Mert Ozan Bahtiyar; Cary P Gross
Journal:  Fetal Diagn Ther       Date:  2022-03-10       Impact factor: 2.208

Review 7.  Pharmacotherapy for Pediatric Neurogenic Bladder.

Authors:  Paweł Kroll
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

Review 8.  Antenatal management of fetal neurosurgical diseases.

Authors:  Sergio Cavalheiro; Marcos Devanir Silva da Costa; Jardel Nicacio Mendonça; Patricia Alesssandra Dastoli; Italo Capraro Suriano; Mauricio Mendes Barbosa; Antonio Fernandes Moron
Journal:  Childs Nerv Syst       Date:  2017-05-29       Impact factor: 1.475

Review 9.  The Management of the Pediatric Neurogenic Bladder.

Authors:  Renea M Sturm; Earl Y Cheng
Journal:  Curr Bladder Dysfunct Rep       Date:  2016-07-02

10.  Prenatal genetic diagnosis: Fetal therapy as a possible solution to a positive test.

Authors:  Aysha Karim Kiani; Stefano Paolacci; Pietro Scanzano; Sandro Michelini; Natale Capodicasa; Leonardo D'Agruma; Angelantonio Notarangelo; Gerolamo Tonini; Daniela Piccinelli; Kalantary Rad Farshid; Paolo Petralia; Ezio Fulcheri; Francesca Buffelli; Pietro Chiurazzi; Corrado Terranova; Francesco Plotti; Roberto Angioli; Marco Castori; Ondrej Pös; Tomas Szemes; Matteo Bertelli
Journal:  Acta Biomed       Date:  2020-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.